Peer-reviewed data shows Gilead's drug helps COVID-19 recovery time

The U.S. National Institutes of Health (NIH) said on Friday peer-reviewed data published in the New England Journal of Medicine show that Gilead Sciences Inc's remdesivir is effective at helping COVID-19 patients recover.

from Reuters: Health News https://ift.tt/3cX5d64